Evaluation of metabolic factors on the prognosis of patients undergoing resection of hepatocellular carcinoma

Journal of Gastroenterology and Hepatology (Australia)

Volumn 26, Issue 3, 2011, Pages 536-543

  Kaibori, Masaki ^a   Ishizaki, Morihiko ^a   Matsui, Kosuke ^a   Kitade, Hiroaki ^a   Matsui, Yoichi ^a   Kwon, A Hon ^a  

^a KANSAI MEDICAL UNIVERSITY HOSPITAL   (Japan)

Author keywords

Angiotensin II blockade; Hepatectomy; Hepatitis C virus; Hypertension; Liver cancer

Indexed keywords

ANGIOTENSIN II ANTAGONIST;

AGED; ARTICLE; CANCER SURGERY; CHRONIC HEPATITIS; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE FREE SURVIVAL; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; HYPERTENSION; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; OBESITY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS;

EID: 79951608525     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2010.06439.x     Document Type: Article

References (33)

1. Bosch X, Ribes J, Borras J. Epidemiology of primary liver cancer. Semin. Liver Dis. 1999; 19: 271-85.
2. Taylor-Robinson SD, Foster GR, Arora S etal. Increase in primary liver cancer in the UK 1979-94. Lancet 1997; 350: 1142-3.
3. EI-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N. Engl. J. Med. 1999; 340: 745-50.
4. Bosch FX, Ribes J, Diaz M etal. Primary liver cancer: worldwide incidence and trends. Gastroenterology 2004; 127: S5-S16.
5. Ferrannini E, Buzzigoli G, Bonadonna R etal. Insulin resistance in essential hypertension. N. Engl. J. Med. 1987; 317: 350-7.
6. Ross R. Atherosclerosis: an inflammatory disease. N. Engl. J. Med. 1999; 340: 115-26.
7. Moller H, Mellemgaard A, Lindvig K etal. Obesity and cancer risk: a Danish record-linkage study. Eur. J. Cancer 1994; 30A: 344-50.
8. Rapp K, Schroeder J, Klenk J etal. Obesity and incidence of cancer: a large cohort study of over 145000 adults in Austria. Br. J. Cancer 2005; 93: 1062-7.
9. Calle EE, Rodriguez C, Walker-Thurmond K etal. Overweight, obesity and mortality from cancer in a prospective studied cohort of US adults. N. Engl. J. Med. 2003; 348: 1625-38.
10. Samanic C, Gridley G, Chow WH etal. Obesity and cancer risk among white and black United States veterans. Cancer Causes Control 2004; 15: 35-43.
11. Nair S, Mason A, Eason J etal. Is obesity an independent risk factor for hepatocellular carcinoma in cirrhosis? Hepatology 2002; 36: 150-5.
12. El-Serag HB, Tran T, Everhart JE. Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology 2004; 126: 460-8.
13. Davila JA, Morgan RO, Shaib Y etal. Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study. Gut 2005; 54: 533-9.
14. Ikeda Y, Shimada M, Hasegawa H etal. Prognosis of hepatocellular carcinoma with diabetes mellitus after hepatic resection. Hepatology 1998; 27: 1567-71.
15. Poon RT, Fan ST, Wong J. Dose diabetes mellitus influence the perioperative outcome or long term prognosis after resection of hepatocellular carcinoma. Am. J. Gastroenterol. 2002; 97: 1480-8.
16. Toyoda H, Kumada T, Nakano S etal. Impact of diabetes mellitus on the prognosis of patients with hepatocellular carcinoma. Cancer 2001; 91: 957-63.
17. Yoshiji H, Kuriyama S, Fukui H. Blockade of renin-angiotensin system in antifibrotic therapy. J. Gastroenterol. Hepatol. 2007; 22: S93-S95.
18. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979; 28: 1039-57.
19. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2008; 31 (Suppl 1): S55-60.
20. Chobanian AV, Bakris GL, Black HR etal. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 2003; 289: 2560-72.
21. Kwon AH, Ha-Kawa SK, Uetsuji S etal. Preoperative determination of the surgical procedure for hepatectomy using technetium-99m-galactosyl human serum albumin (99mTc-GSA) liver scintigraphy. Hepatology 1997; 25: 426-9.
22. Strasberg SM, Belghiti J, Clavn P-A etal. The Brisbane 2000 terminology of liver anatomy and resection. Terminology Committee of the International Hepato-Pancreato-Biliary Association. HPB 2000; 2: 333-9.
23. Couinaud C, ed. Le Foie: Etudes Anatomiques Et Chirurgicales. Paris: Masson, 1957.
24. Sobin LH, Wittekind C, eds. TNM Classification of Malignant Tumours, 5th edn. New York: Wiley, 1997.
25. Chen CL, Yang H, Yang WS etal. Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan. Gastroenterology 2008; 135: 111-21.
26. Shiratori Y, Shiina S, Imamura M etal. Characteristic difference of hepatocellular carcinoma between hepatitis B- and C- viral infection in Japan. Hepatology 1995; 22: 1027-33.
27. Miyagawa S, Kawasaki S, Makuuchi M. Comparison of the characteristics of hepatocellular carcinoma between hepatitis B and C viral infection: tumor multicentricity in cirrhotic liver with hepatitis C. Hepatology 1996; 24: 307-10.
28. Kubo S, Nishiguchi S, Hirohashi K etal. Clinicopathological criteria for multicentricity of hepatocellular carcinoma and risk factors for such carcinogenesis. Jpn. J. Cancer Res. 1998; 89: 419-26.
29. Shuto T, Hirohashi K, Kubo S etal. Differences of resected hepatocellular carcinoma with hepatitis B or C virus. Hepatogastroenterology 1998; 45: 1722-5.
30. Grossman E, Messerli FH, Boyko V etal. Is there an association between hypertension and cancer mortality? Am. J. Med. 2002; 112: 479-86.
31. Chow WH, Gridley G, Fraumeni JF etal. Obesity, hypertension, and the risk of kidney cancer in men. N. Engl. J. Med. 2000; 343: 1305-11.
32. Yoshiji H, Noguchi R, Ikenaka Y etal. Renin-angiotensin system inhibitors as therapeutic alternatives in the treatment of chronic liver diseases. Curr. Med. Chem. 2007; 14: 2749-54.
33. Corey KE, Shah N, Misdraji J etal. The effect of angiotensin-blocking agents on liver fibrosis in patients with hepatitis C. Liver International. 2009; 29: 748-53.